Michael Panzara
2020
In 2020, Michael Panzara earned a total compensation of $831.4K as Chief Medical Officer, Head of Therapeutics Discovery and Development at Wave Life Sciences Ltd., a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $184,344 |
|---|---|
| Option Awards | $176,386 |
| Salary | $460,860 |
| Other | $9,792 |
| Total | $831,382 |
Panzara received $460.9K in salary, accounting for 55% of the total pay in 2020.
Panzara also received $184.3K in non-equity incentive plan, $176.4K in option awards and $9.8K in other compensation.
Rankings
In 2020, Michael Panzara's compensation ranked 9,346th out of 13,090 executives tracked by ExecPay. In other words, Panzara earned more than 28.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,346 out of 13,090 | 29th |
Division Manufacturing | 3,990 out of 5,617 | 29th |
Major group Chemicals And Allied Products | 1,622 out of 2,248 | 28th |
Industry group Drugs | 1,419 out of 1,948 | 27th |
Industry Pharmaceutical Preparations | 1,041 out of 1,453 | 28th |
Source: SEC filing on June 29, 2022.
Panzara's colleagues
We found two more compensation records of executives who worked with Michael Panzara at Wave Life Sciences Ltd. in 2020.